Latest news for Cadeler (OTC:CADLF) Stock

Cadeler AS is an offshore wind farm vessel contractor. It is engaged in offshore wind farm construction, maintenance, and decommissioning, and provides marine and engineering operations to the wind industry with a focus on safety and the environment. The company operates four offshore jack-up wind farm installation vessels. In addition to wind farm installation, these vessels can perform maintenance, construction, decommissioning, and other tasks within the offshore industry.

Cadeler AS

Morgan Stanley analyst Martijn Rats downgrades TotalEnergies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) from Overweight to Equal-Weight and lowers the price target from $70.4 to $64.1.

News

Downgrades

Price Target

Analyst Ratings

Morgan Stanley Downgrades TotalEnergies to Equal-Weight, Lowers Price Target to $64.1

Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) shares are trading higher premarket on Tuesday after the ride-ailing company and NVIDIA Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) entered into a strategic partnership aimed at advancing AI-powered <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42836060/uber-teams-up-with-nvidia-to-accelerate-autonomous-mobility" rel="noreferrer noopener">autonomous vehicle (AV) technology</a>.
The collaboration will leverage NVIDIA&#8217;s platforms, including Cosmos and DGX Cloud, to accelerate the development of autonomous driving solutions.
NVIDIA Cosmos is a state-of-the-art platform designed to support the development of physical AI systems like robots and autonomous vehicles, eliminating cost and resource limitations, making it easier for developers to build and deploy AI models at scale.
Additionally, NVIDIA DGX Cloud offers a high-performance, fully managed environment for AI model development.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42812603/uber-cfo-highlights-undervalued-stock-while-accelerating-buyback-efforts-through-15-billion-asr-deal" rel="noreferrer noopener">Uber CFO Says Stock Undervalued, Initiates $1.5 Billion Accelerated Stock Buyback</a>
By combining Uber&#8217;s trove of mobility data with NVIDIA&#8217;s AI technology, both companies plan to create more efficient and scalable AI models for the industry.
&#8220;Generative AI will power the future of mobility, requiring both rich data and very powerful compute,&#8221;&nbsp;said Uber CEO Dara Khosrowshahi.
&#8220;By working with NVIDIA, we are confident that we can help supercharge the timeline for safe and scalable autonomous driving solutions for the industry.&#8221;
In his keynote address at the <a target="_blank" href="https://www.benzinga.com/news/global/25/01/42836461/nvidias-ces-2025-vision-sparks-mixed-reactions-ross-gerber-hails-incredible-things-to-come-while-analysts-debate-ai-and-autonomous-driving-ambitions" rel="noreferrer noopener">CES 2025 on Monday</a>, NVIDIA CEO&nbsp;Jensen Huang&nbsp;predicted that self-driving vehicles would become &#8220;the first multi-trillion dollar robotics industry.&#8221;
Nvidia will also deploy its Drive AGX&nbsp;Orin supercomputer and operating system for advanced driver assistance features on Toyota Motor Corp&#8216;s <a target="_blank" href="https://www.benzinga.com/25/01/42836673/toyotas-next-gen-vehicles-to-use-nvidia-supercomputer-operating-system" rel="noreferrer noopener">next-generation models</a>.
&#8220;NVIDIA is bringing two decades of automotive computing, safety expertise and its CUDA AV platform to transform the multitrillion dollar auto industry,&#8221; said Huang.
Price Action: UBR shares are trading higher by 2.26% at $67.81 in premarket at last check Tuesday.
Related Read:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/42801896/uber-ceo-dara-khosrowshahi-resigns-from-board-of-autonomous-vehicle-tech-company-aurora" target="_blank" rel="noreferrer noopener">Uber CEO Dara Khosrowshahi Resigns From Board Of Autonomous Vehicle Tech Company Aurora</a></li>
</ul>
Image via Shutterstock.

Equities

Movers

General

NVDA

UBER

Uber And NVIDIA Partner On AI Technology For Autonomous Cars

HC Wainwright &amp; Co. analyst Emily Bodnar maintains Acelyrin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLRN#NASDAQ">SLRN</a>) with a Neutral and lowers the price target from $8 to $6.

SLRN

HC Wainwright & Co. Maintains Neutral on Acelyrin, Lowers Price Target to $6

GETY

SSTK

Getty Images And Shutterstock Announce Merger Agreement For $3.7B

Wells Fargo &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) will release earnings for its fourth quarter before the opening <a href="https://www.benzinga.com/quote/WFC/earnings">bell on Wednesday, Jan. 15.</a>
Analysts expect the San Francisco, California-based company to report quarterly earnings at $1.34 per share, up from 86 cents per share in the year-ago period. Wells Fargo projects to report quarterly revenue of $20.6 billion, compared to $20.48 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Wells Fargo Bank, N.A. slashed its prime rate to 7.50% from 7.75%, effective Dec. 19, 2024.
Wells Fargo shares gained 2.2% to close at $72.86 on Monday&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/WFC/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>JP Morgan analyst Michael Rehaut maintained a Neutral rating and cut the price target from $92.5 to $82 on Dec. 13, 2024. This analyst has an accuracy rate of 71%.</li>
<li>Barclays analyst Matthew Bouley downgraded the stock from Overweight to Equal-Weight and cut the price target from $99 to $85 on Dec. 11, 2024. This analyst has an accuracy rate of 73%.</li>
<li>Wedbush analyst Jay McCanless maintained a Neutral rating and raised the price target from $67 to $75 on Sept. 25, 2024. This analyst has an accuracy rate of 87%.</li>
<li>B of A Securities analyst Rafe Jadrosich maintained a Neutral rating and boosted the price target from $75 to $90 on Sept. 19, 2024. This analyst has an accuracy rate of 67%.</li>
<li>RBC Capital analyst Mike Dahl downgraded the stock from Sector Perform to Underperform with a price target of $70 on Sept. 5, 2024. This analyst has an accuracy rate of 72%.</li>
</ul>
Considering buying WFC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="603" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07062208/image-26-1024x603.png" alt="" class="wp-image-721567" style="width:591px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07062208/image-26-1024x603.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07062208/image-26-300x177.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07062208/image-26-768x453.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/07062208/image-26.png 1103w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<a href="https://www.benzinga.com/25/01/42820522/jpmorgan-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">JPMorgan Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a>

Earnings

Markets

Trading Ideas

Wells Fargo Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Morgan Stanley analyst Martijn Rats maintains BP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BP#NYSE">BP</a>) with a Equal-Weight and lowers the price target from $34.7 to $31.8.

Morgan Stanley Maintains Equal-Weight on BP, Lowers Price Target to $31.8

Morgan Stanley analyst Martijn Rats downgrades Eni (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/E#NYSE">E</a>) from Overweight to Equal-Weight and lowers the price target from $37.5 to $31.6.

Morgan Stanley Downgrades Eni to Equal-Weight, Lowers Price Target to $31.6

The CNN Money Fear and Greed index showed some easing in the overall fear level, while the index remained in the &#8220;Fear&#8221; zone on Monday.
U.S. stocks settled mostly higher on Monday, with the S&amp;P 500 and Nasdaq Composite recording back-to-back gains during the session.
Chip stocks were among the top gainers of the session after Foxconn disclosed record revenue for the fourth quarter. Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) shares gained 3.4%, while Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) jumped 10.5% on Monday.
Among Monday's notable headlines, The Washington Post reported Donald Trump's economic team is exploring a more targeted version of its universal tariff plan, aiming to apply tariffs to specific sectors rather than implementing a broad measure on all imports.
On the economic data front, the S&amp;P Global services PMI was revised downward to 56.8 in December compared to a preliminary reading of 58.5, and versus a reading of 56.1 in November.
Most sectors on the S&amp;P 500 closed on a negative note, with consumer staples, utilities, and real estate stocks recording the biggest losses on Monday. However, communication services and information technology stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed lower by around 26 points to 42,706.56 on Monday. The S&amp;P 500 gained 0.55% to 5,975.38, while the Nasdaq Composite climbed 1.24% at 19,864.98 during Monday's session.
Investors are awaiting earnings results from RPM International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RPM#NYSE">RPM</a>), AAR Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIR#NYSE">AIR</a>), and Cal-Maine Foods Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALM#NASDAQ">CALM</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 36.7, the index remained in the &#8220;Fear&#8221; zone on Monday, versus a prior reading of 33.3.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42820522/jpmorgan-earnings-are-imminent-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">JPMorgan Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>
Photo courtesy: Shutterstock

Pre-Market Outlook

CALM

Nasdaq Jumps Over 1% As Nvidia, Micron Surge: Investor Fear Eases, But Greed Index Remains In 'Fear' Zone

Morgan Stanley analyst Martijn Rats upgrades Equinor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQNR#NYSE">EQNR</a>) from Equal-Weight to Overweight and raises the price target from $25.8 to $30.9.

Upgrades

EQNR

Morgan Stanley Upgrades Equinor to Overweight, Raises Price Target to $30.9

Canaccord Genuity analyst William Plovanic downgrades Inari Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NARI#NASDAQ">NARI</a>) from Buy to Hold and raises the price target from $74 to $80.

NARI

Canaccord Genuity Downgrades Inari Medical to Hold, Raises Price Target to $80

Morgan Stanley analyst Martijn Rats upgrades Shell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) from Equal-Weight to Overweight and raises the price target from $66.5 to $79.8.

SHEL

Morgan Stanley Upgrades Shell to Overweight, Raises Price Target to $79.8

HC Wainwright &amp; Co. analyst Heiko Ihle maintains US Goldmining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USGO#NASDAQ">USGO</a>) with a Buy and raises the price target from $24 to $26.5.

USGO

HC Wainwright & Co. Maintains Buy on US Goldmining, Raises Price Target to $26.5

Evercore ISI Group analyst Elizabeth Anderson downgrades Dentsply Sirona (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRAY#NASDAQ">XRAY</a>) from Outperform to In-Line and announces $20 price target.

XRAY

Evercore ISI Group Downgrades Dentsply Sirona to In-Line, Announces $20 Price Target

Thermal Management Services Provider Modine To Open A New Facility In Chennai, India, In Mid-2025

Needham analyst Chris Pierce reiterates Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) with a Buy and maintains $330 price target.

Reiteration

CVNA

Needham Reiterates Buy on Carvana, Maintains $330 Price Target

Evercore ISI Group analyst Elizabeth Anderson upgrades Cardinal Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAH#NYSE">CAH</a>) from In-Line to Outperform and maintains the price target from $140 to $140.

Evercore ISI Group Upgrades Cardinal Health to Outperform, Maintains Price Target to $140

<ul>
<li>The Nodify CDT test measures levels of seven autoantibodies associated with lung cancer that can be detected in blood samples of patients with indeterminate lung nodules. Prior studies have demonstrated that elevated levels of the autoantibodies indicate a likely cancerous nodule (referred to as a "rule in" test) and may lead to escalation of care to diagnose lung cancer earlier. The test is often ordered in conjunction with the Nodify XL2&#xAE; blood-based lung nodule test, designed to identify likely benign nodules (referred to as a "rule out" test). The combination of the two tests, marketed as Nodify Lung Nodule Risk Assessment, reclassifies the risk of lung cancer to help identify the most appropriate diagnostic pathway.&nbsp;</li>
<li>The newly published study included 447 patients with lung nodules managed conventionally without the use of the Nodify CDT or Nodify XL2 tests. In this cohort, 33% of patients with cancerous nodules received a diagnosis more than three months after lung nodule detection, representing a missed opportunity for early detection, which may have improved patient outcomes. The Nodify CDT test was performed retrospectively to analyze test performance.&nbsp;</li>
<li>The primary findings of the study demonstrated that the Nodify CDT test maintained a high specificity, meaning that a very low percentage of benign nodules were misclassified as high risk. The Nodify CDT test performance was also compared to that of positron emission tomography (PET) scans, an imaging modality commonly used to assess lung nodule risk. In the 222 patients receiving PET scans, the Nodify CDT test demonstrated higher specificity, meaning that PET scans had significantly more false positive results. Because PET scans are often used to guide clinical decision making in patients with lung nodules, a false positive can lead to an unnecessary invasive procedure that carries the risk of complications and cost to the patient and healthcare system.&nbsp;</li>
</ul>

Health Care

BDSX

Biodesix Announced A New Post-market Clinical Validation Study Was Published In CHEST Pulmonary Journal That Reaffirms The Performance Of Nodify CDT Blood-based Lung Nodule Test

Evercore ISI Group analyst David Palmer downgrades Kraft Heinz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) from Outperform to In-Line and lowers the price target from $38 to $35.

Evercore ISI Group Downgrades Kraft Heinz to In-Line, Lowers Price Target to $35

EV giant Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) on Monday reminisced about delivering the first Model 3 cars made at the company&#8217;s gigafactory in Shanghai.
What Happened: &#8220;Five years ago today, the first Model 3 cars produced at Giga Shanghai were delivered to our customers. Since then, Giga Shanghai has produced over 3 million vehicles, about one-third of which have been exported to markets worldwide,&#8221; Tesla said in a post on social media platform X. 
Tesla&#8217;s gigafactory in Shanghai manufactures the company&#8217;s Model Y SUV and Model 3 sedans for sale in China and export to foreign countries including Europe. As per the company&#8217;s recent quarterly report published in October, the company has a currently installed annual vehicle capacity of over 950,000 vehicles
The company achieved a <a href="https://www.benzinga.com/news/24/10/41303692/teslas-giga-shanghai-hits-3-million-production-milestone-celebrates-with-red-model-rollout">3 million production milestone </a>at the factory in October. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Five years ago today, the first Model 3 cars produced at Giga Shanghai were delivered to our customers. Since then, Giga Shanghai has produced over 3 million vehicles, about one-third of which have been exported to markets worldwide, earning widespread acclaim! &#x1f389; Thanks to our… <a href="https://t.co/2n7sy7SBcX">pic.twitter.com/2n7sy7SBcX</a>
&mdash; Tesla Asia (@Tesla_Asia) <a href="https://twitter.com/Tesla_Asia/status/1876449515127124402?ref_src=twsrc%5Etfw">January 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Tesla&#8217;s Model 3 currently starts at 231,900 yuan in China with the more premium Performance variant starting at 335,900 yuan. The Model Y SUV, in comparison, starts at 249,900 yuan.
China is an important market for Tesla. In 2024, the company reportedly <a href="https://www.benzinga.com/25/01/42782683/tesla-hits-record-ev-sales-in-china-despite-global-dip">sold around 657,000 vehicles in China</a>, marking a growth of 8.8% year-on-year, even while its global annual deliveries fell as compared to 2023.
Tesla reported global <a href="https://www.benzinga.com/trading-ideas/movers/25/01/42766117/tesla-stock-tumbles-on-q4-deliveries-whats-going-on" target="_blank" rel="noreferrer noopener">deliveries of 1.79 million</a> vehicles in 2024, down from full-year deliveries of 1.81 million in 2023 and marking the first decline in over a decade.
Tesla is now putting up a mega factory in China aimed at the production of its energy storage products. The company started trial production at the factory in December before formally starting mass production in the first quarter of 2025.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42836673/toyotas-next-gen-vehicles-to-use-nvidia-supercomputer-operating-system" target="_blank" rel="noreferrer noopener">Nvidia Supercomputer, Operating System To Power Toyota's Next-Gen Vehicles</a></li>
</ul>
Photo courtesy: Shutterstock

Comments

Cadeler

News

Latest news for Cadeler (OTC:CADLF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga